|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|
| Cash Flows from Operating Activities | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Gain on marketable securities (net), dividends and interest, held in Trust Account | |
| Transaction costs allocated to derivative warrant liabilities | |
| Formation and operating expenses funded by related party | |
| Change in fair value of derivative warrant liabilities | |
| Changes in operating assets and liabilities: | |
| Prepaid and other assets | |
| Accounts payable | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities | |
| Investment of cash into Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities | |
| Proceeds from note payable and advances from related party | |
| Repayment of note payable and advances from related party | |
| Proceeds from sale of Class A ordinary shares, gross | |
| JGGC Sponsor | |
| Total proceeds from sale of Class A ordinary shares, gross | |
| Proceeds from sale of Private Placement Warrants | |
| Offering costs paid | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash—beginning of period | |
| Cash—end of period | |
| Supplemental disclosure of noncash investing and financing activities: | |
| Offering costs included in accounts payable | |
| Offering costs included in accrued expenses | |
| Deferred underwriting fees payable |
Loading...
